Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti-apoptotic pathways

BACKGROUND: Despite recent advances in diagnosis and treatment, prostate cancer (PCa) remains the leading cause of cancer-related deaths in men. Current treatments offered in the clinics are often toxic and have severe side effects. Hence, to treat and manage PCa, new agents with fewer side effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Ward, Ashley B., Mir, Hina, Kapur, Neeraj, Gales, Dominique N., Carriere, Patrick P., Singh, Shailesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001031/
https://www.ncbi.nlm.nih.gov/pubmed/29898731
http://dx.doi.org/10.1186/s12957-018-1400-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001031/
https://www.ncbi.nlm.nih.gov/pubmed/29898731
http://dx.doi.org/10.1186/s12957-018-1400-z

Ejemplares similares